Spots Global Cancer Trial Database for endometrial cancer recurrent
Every month we try and update this database with for endometrial cancer recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer | NCT03015129 | Endometrial Can... Endometrial Car... Endometrial Car... Endometrial Can... Endometrial Car... | Durvalumab Tremelimumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors | NCT05410717 | Stage IV Ovaria... Testis Cancer, ... Endometrial Can... CAR NK | Claudin6, GPC3,... | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer | NCT04030429 | Endometrial Can... | Crizotinib 250 ... | 20 Years - 75 Years | National Cheng-Kung University Hospital | |
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer | NCT02922764 | Endometrial Can... Endometrial Can... Lung Cancer Rec... Lung Cancer Non-small Cell ... Non-small Cell ... | RGX-104 Ipilimumab Docetaxel Pembrolizumab Carboplatin Pemetrexed | 18 Years - | Inspirna, Inc. | |
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer | NCT03015129 | Endometrial Can... Endometrial Car... Endometrial Car... Endometrial Can... Endometrial Car... | Durvalumab Tremelimumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | NCT03485729 | Endometrial Can... | ONC201 | 18 Years - | Chimerix | |
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | NCT03485729 | Endometrial Can... | ONC201 | 18 Years - | Chimerix | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | NCT03485729 | Endometrial Can... | ONC201 | 18 Years - | Chimerix | |
| Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer | NCT04030429 | Endometrial Can... | Crizotinib 250 ... | 20 Years - 75 Years | National Cheng-Kung University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
